Two Doses of China's Sinovac Inadequate Against Omicron, Hong Kong Study Suggests
The research suggests that the Chinese vaccine had little effect against Omicron and that the efficacy of the Pfizer-BioNTech vaccine seemed to wane.
Full Article
Two Doses of China's Sinovac Inadequate Against Omicron, Hong Kong Study Suggests
NYTimes.com
0 shares
2 views
You might like
Related news coverage
What Is Omicron's Current U.S. Impact?
Watch VideoThe holiday season also means holiday travel, and that means navigating COVID protocols in airports, hotels, or even..
Newsy
China’s Sinovac offers inadequate protection against Omicron, study shows
Hong Kong researchers say two doses of the jab provided ‘insufficient’ antibodies against new variant
FT.com